NDC product
CAPSULE · Catalent Pharma Solution, LLC
NDC 11014-0470 · Catalent Pharma Solution, LLC
Key facts
| Product NDC | 11014-0470 |
|---|---|
| Nonproprietary name | Tivozanib |
| Substances | TIVOZANIB HYDROCHLORIDE |
| Dosage form | CAPSULE |
| Labeler | Catalent Pharma Solution, LLC |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | EXPORT ONLY |
| Marketing start | Aug 24, 2017 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: